2014
DOI: 10.1080/00325481.2015.993268
|View full text |Cite
|
Sign up to set email alerts
|

Safety of a novel formulation of ibuprofen sodium compared with standard ibuprofen and placebo

Abstract: IBU(Na) has a favorable safety profile comparable to those of standard IBU tablets and placebo in single-dose studies evaluating analgesic or antipyretic efficacy. ClinicalTrials.gov Registry Numbers: Dental pain studies: NCT01098747 and NCT01216163; headache studies: NCT01077973 and NCT01362491; pyresis study: NCT01035346.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2015
2015
2017
2017

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 18 publications
0
1
0
Order By: Relevance
“…The common tipyretics drugs are applied in clinic are acetylsalicylic acid, acetaminophen, phenacetin, aminopyrin and ibuprofen [6][7][8] …”
Section: Antipyretics In Applicationmentioning
confidence: 99%
“…The common tipyretics drugs are applied in clinic are acetylsalicylic acid, acetaminophen, phenacetin, aminopyrin and ibuprofen [6][7][8] …”
Section: Antipyretics In Applicationmentioning
confidence: 99%